Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities?

Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities?

Item
http://www.wikidata.org/entity/Q38218909
Eosinophilia in Hematologic DisordersMethotrexate Is a JAK/STAT Pathway InhibitorBCR-JAK2 drives a myeloproliferative neoplasm in transplanted mice.Chronic myelomonocytic leukemia prognostic classification and management: evidence base and current practice.Myelodysplastic syndrome with t(9;22)(p24;q11.2), a BCR-JAK2 fusion: case report and review of the literature.The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours.PDGFRᵝ-Rearranged Myeloid Neoplasm with Marked Eosinophilia in a 37-Year-Old Man; And a Literature Review.A t(8;9)(p22;p24)/PCM1-JAK2 translocation in a patient with myeloproliferative neoplasm and myeloid sarcoma: first report in Korea.Fusion of PDGFRB to MPRIP, CPSF6, and GOLGB1 in three patients with eosinophilia-associated myeloproliferative neoplasms.Guideline for the investigation and management of eosinophilia.
P2860

Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities?

Item
http://www.wikidata.org/entity/Q38218909
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Should myeloid and lymphoid ne ...... cognized as specific entities?
@en
type
label
Should myeloid and lymphoid ne ...... cognized as specific entities?
@en
prefLabel
Should myeloid and lymphoid ne ...... cognized as specific entities?
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Should myeloid and lymphoid ne ...... cognized as specific entities?
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698